Key stats
About iShares Healthcare Innovation UCITS ETF
Home page
Inception date
Sep 8, 2016
Structure
Irish VCIC
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
BlackRock Asset Management Ireland Ltd.
ISIN
IE00BYZK4776
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the STOXX Global Breakthrough Healthcare Index
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.73%
Health Technology90.06%
Health Services4.92%
Commercial Services2.81%
Technology Services1.32%
Finance0.43%
Electronic Technology0.20%
Bonds, Cash & Other0.27%
Cash0.27%
Stock breakdown by region
North America60.15%
Europe27.26%
Asia11.08%
Oceania1.51%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
2B78 invests in stocks. The fund's major sectors are Health Technology, with 90.06% stocks, and Health Services, with 4.92% of the basket. The assets are mostly located in the North America region.
2B78 top holdings are Gilead Sciences, Inc. and Insulet Corporation, occupying 2.71% and 2.56% of the portfolio correspondingly.
2B78 assets under management is 785.73 M EUR. It's fallen 1.52% over the last month.
2B78 fund flows account for −128.81 M EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 2B78 doesn't pay dividends to its holders.
2B78 shares are issued by BlackRock, Inc. under the brand iShares. The ETF was launched on Sep 8, 2016, and its management style is Passive.
2B78 expense ratio is 0.40% meaning you'd have to pay 0.40% of your investment to help manage the fund.
2B78 follows the STOXX Global Breakthrough Healthcare (USD)(NR). ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
2B78 invests in stocks.
2B78 price has fallen by −0.45% over the last month, and its yearly performance shows a −6.55% decrease. See more dynamics on 2B78 price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −1.37% over the last month, showed a −8.31% decrease in three-month performance and has decreased by −5.52% in a year.
NAV returns, another gauge of an ETF dynamics, have fallen by −1.37% over the last month, showed a −8.31% decrease in three-month performance and has decreased by −5.52% in a year.
2B78 trades at a premium (0.27%) meaning the ETF is trading at a higher price than the calculated NAV.